id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-335916-fh28qrt7	Liu, Cuiwei	COVID-19 in cancer patients: risk, clinical features, and management	2020-08-15		.txt	text/plain	3937	189	40	Cancer patients are regarded as a highly vulnerable population to SARS-CoV-2 infection and development of more severe COVID-19 symptoms, which is possibly due to the systemic immunosuppressive state caused directly by tumor growth and indirectly by effects of anticancer treatment. Another cohort study of 28 COVID-19 cancer patients reported that patients with Stage IV disease accounted for a higher percentage of infected patients (35.7%), suggesting that later stage cancer patients may be more susceptible to SARS-CoV-2 5 . Notably, a retrospective study of 28 COVID-19 cancer patients found that anti-cancer treatment within 14 days before COVID-19 diagnosis was more frequently associated with severe clinical events due to SARS-CoV-2 infection 5 . The higher proportion of COVID-19 patients with cancer requiring oxygen therapy and mechanical ventilation may be related to more severe disease and an immunosuppressive state in cancer patients, who are more susceptible to secondary lung infection with other pathogens.	./cache/cord-335916-fh28qrt7.txt	./txt/cord-335916-fh28qrt7.txt